In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Boehringer Ingelheim, NeuroSearch develop CNS drug

Executive Summary

In its largest deal to date, Danish biotech company NeuroSearch (central nervous system therapeutics) has licensed Boehringer Ingelheim development and marketing rights to its drug candidate NS2330, a small-molecule neurotransmitter enhancer to treat Alzheimer's and Parkinson's diseases.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies

UsernamePublicRestriction

Register